Chapter title |
Atopic Dermatitis: Managing the Itch
|
---|---|
Chapter number | 13 |
Book title |
Management of Atopic Dermatitis
|
Published in |
Advances in experimental medicine and biology, January 2017
|
DOI | 10.1007/978-3-319-64804-0_13 |
Pubmed ID | |
Book ISBNs |
978-3-31-964803-3, 978-3-31-964804-0
|
Authors |
William S. Farmer, Kalyani S. Marathe, Farmer, William S., Marathe, Kalyani S. |
Abstract |
Atopic dermatitis has a substantial impact on sleep, appearance, psychological well-being, and other qualities of life. The visual appearance of lichenification, cheilitis, hyperpigmentation, ichthyosis, and erythema can be socially stigmatizing, and treatment of these symptoms is challenging. In managing pruritus in patients, practitioners should assess and document pruritus through questionnaires at each routine visit. Initially, practitioners should advise patients to employ non-pharmaceutical treatments such as emollients with wet wraps, elimination of triggers, changing scratching habits, and psychological interventions. If these methods of treatment are not successful or if the disease presentation is severe, pharmacological therapies should be employed. This chapter describes the therapeutic ladder for pruritus in atopic dermatitis and discusses each treatment modality in further detail for practitioners to advise their patients.First-line topical pharmaceutical agents include topical glucocorticoids and topical calcineurin inhibitors. Second-line topical agents include coal tar, menthol, capsaicin, or doxepin. After the use of topical agents has been exhausted, primary systemic agents can be applied. These include sedating antihistamines, non-sedating antihistamines, oral glucocorticoids, or cyclosporine A. Finally, neuromodulating or immunomodulating agents can be attempted, including SSRI/SNRIs, TCAs, immunosuppressants, neural modulators, and opioid receptor modulators. Outside of pharmacological treatments, phototherapy has been shown to provide a dramatic improvement of pruritus in atopic dermatitis and can be used at any stage of treatment including as a first-line agent. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 36 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 8 | 22% |
Student > Ph. D. Student | 4 | 11% |
Student > Master | 3 | 8% |
Student > Doctoral Student | 2 | 6% |
Student > Postgraduate | 2 | 6% |
Other | 3 | 8% |
Unknown | 14 | 39% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 22% |
Biochemistry, Genetics and Molecular Biology | 3 | 8% |
Psychology | 3 | 8% |
Neuroscience | 2 | 6% |
Social Sciences | 2 | 6% |
Other | 2 | 6% |
Unknown | 16 | 44% |